Salmeterol is the first long acting selective β2 agonist with a slow onset of action; used by inhalation on a twice daily schedule for maintenance therapy and for occurring asthma, but not for acute symptoms. Salmeterol reduces breathlessness by preventing expiratory closure of peripheral airways and abolishing the reversible component of airway obstruction. Fluticasone is an Inhaled steroid it suppresses bronchial inflammation, increases peak expiratory flow rate, reduces the need for rescue β2-agonist inhalations, and prevents episodes of acute asthma.
As per the best practices of the company, we assure you that the information provided herein is factual,
truthful, up-to-date, and complete. It is very important to note that this report should not be used in lieu
of physical medical consultation/advice. We do not guarantee the authenticity or credibility of the
data/information presented. The absence of any details and/or warning/notice to any drugs & medicine
shall not be deemed or assumed to be an implied assurance of the Company. We accept no
responsibility for the consequences due to the aforementioned data/information and in case of any
doubts or queries, we strongly advise you to seek a physical consultation.